Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0483 | 0.0724 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0483 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0409 | 0.042 |
Onchocerca volvulus | 0.0095 | 0.1811 | 1 | |
Brugia malayi | hypothetical protein | 0.0035 | 0.0483 | 0.0453 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.0483 | 0.0483 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.012 | 0.2351 | 0.2351 |
Schistosoma mansoni | thyroid hormone receptor | 0.0136 | 0.2717 | 1 |
Echinococcus multilocularis | lamin | 0.0027 | 0.0308 | 0.0308 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0032 | 0.0409 | 0.0379 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0466 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0173 | 0.3525 | 0.5 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0466 | 1 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0095 | 0.1811 | 0.6238 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.1218 | 0.3778 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0027 | 0.0308 | 0.0278 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0061 | 0.1054 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0466 | 1 | 1 |
Echinococcus granulosus | lamin | 0.0027 | 0.0308 | 0.0308 |
Echinococcus multilocularis | lamin dm0 | 0.0027 | 0.0308 | 0.0308 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0061 | 0.1054 | 0.5 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0136 | 0.2717 | 0.2717 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0483 | 0.5 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0095 | 0.1811 | 0.1785 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0032 | 0.0409 | 0.0409 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0483 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0126 | 0.2494 | 0.9073 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0061 | 0.1054 | 0.1054 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0068 | 0.1218 | 0.119 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0061 | 0.1054 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.01 | 0.1915 | 0.189 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0032 | 0.0409 | 0.0409 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.01 | 0.1915 | 0.189 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0409 | 0.042 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0032 | 0.0409 | 0.0409 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0126 | 0.2494 | 0.2494 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.01 | 0.1915 | 0.1915 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.0483 | 0.0483 |
Echinococcus granulosus | intermediate filament protein | 0.0027 | 0.0308 | 0.0308 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0297 | 0.0297 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0126 | 0.2494 | 0.2494 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0027 | 0.0308 | 0.0308 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0061 | 0.1054 | 0.3097 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0061 | 0.1054 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0409 | 0.042 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0308 | 0.0308 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0409 | 0.0409 |
Echinococcus granulosus | lamin dm0 | 0.0027 | 0.0308 | 0.0308 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0014 | 0.0032 | 0.0032 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.0483 | 0.0724 |
Schistosoma mansoni | hypothetical protein | 0.0095 | 0.1811 | 0.6238 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0061 | 0.1054 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0178 | 0.3632 | 0.3632 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.1915 | 0.1915 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0409 | 0.042 |
Schistosoma mansoni | thyroid hormone receptor | 0.0136 | 0.2717 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.012 | 0.2351 | 0.2351 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0061 | 0.1054 | 0.1054 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0032 | 0.0409 | 0.0409 |
Brugia malayi | intermediate filament protein | 0.0027 | 0.0308 | 0.0278 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0061 | 0.1054 | 0.3097 |
Echinococcus multilocularis | GPCR, family 2 | 0.0032 | 0.0409 | 0.0409 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.1218 | 0.1218 |
Brugia malayi | MH2 domain containing protein | 0.012 | 0.2351 | 0.2326 |
Echinococcus multilocularis | musashi | 0.0027 | 0.0308 | 0.0308 |
Echinococcus granulosus | GPCR family 2 | 0.0032 | 0.0409 | 0.0409 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0032 | 0.0409 | 0.0409 |
Brugia malayi | Voltage-gated calcium channel, T-type, alpha subunit. C. elegans cca-1 ortholog | 0.0178 | 0.3632 | 0.3612 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0483 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0032 | 0.0409 | 0.0379 |
Loa Loa (eye worm) | intermediate filament protein | 0.0027 | 0.0308 | 0.0308 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0061 | 0.1054 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.